Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation <i>via</i> altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals
PaperCitations, authors & open-access status
Anti‐androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation <i>via</i> altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 57 citations, 2015 year and bronze oa status.
57
Citations
2015
Year
bronze
OA Status